Stryker sees FY23 adjusted EPS $10.05-$10.25, consensus $10.03

Sees FY23 organic net sales growth to be in the range of 8.0%-9.0%. Expects pricing to be relatively neutral for the year. If foreign exchange rates hold near their current levels, anticipates full year sales and EPS will be modestly unfavorably impacted for the full year, being more negative in the first half of the year.